{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:56:43Z","timestamp":1787162203177,"version":"build-2736575974"},"reference-count":22,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The Duchossois Family Institute"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>The intestinal microbiome is composed of myriad microbial species with impacts on host health that are mediated by the production of metabolites. While loss of bacterial species and beneficial metabolites from the fecal microbiome is associated with development of a range of diseases and medical complications, there are currently no clinical diagnostic tests that rapidly identify individuals with microbiome deficiencies. This method aims to rapidly quantify fecal concentrations of butyrate and deoxycholic acid, as depletion of these two metabolites are associated with adverse clinical outcomes and result from the loss of a subset of health-associated bacterial species. We present a rapid diagnostic screen based on 3-nitrophenylhydrazine derivatization and ultrahigh-performance liquid chromatography-mass spectrometry that measures fecal butyrate and deoxycholic acid concentrations as markers of microbiome function. A matrix-matched calibration curve was developed using a simulated fecal mixture to optimize accuracy and facilitate adherence to clinical laboratory regulations. The assay resulted in an analytical measurement range from 4.30\u20133030 \u00b5M (LLOQ\u2009=\u20093.71 \u00b5M) for butyrate and from 0.9\u201364.9 \u00b5M (LLOQ\u2009=\u20090.7 \u00b5M) for deoxycholic acid. Precision evaluation demonstrated a coefficient of variation &lt;15% at all quality control levels tested. The rapid liquid chromatography-mass spectrometry screen can be performed in under an hour from extraction to provision of quantitative results, enabling the rapid identification of patients with defective microbiome function.<\/jats:p>","DOI":"10.1371\/journal.pone.0337727","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T18:34:47Z","timestamp":1767983687000},"page":"e0337727","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Fecal butyrate and deoxycholic acid quantitation for rapid assessment of the gut microbiome"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2884-4307","authenticated-orcid":true,"given":"Michael W.","family":"Mullowney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4013-2182","authenticated-orcid":true,"given":"Angelica","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7883-4852","authenticated-orcid":true,"given":"Antonio","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"McMillin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1388-0305","authenticated-orcid":true,"given":"Amber R.","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Little","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann B.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhakti K.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Odenwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric G.","family":"Pamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiang-Teck J.","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8670-9090","authenticated-orcid":true,"given":"Ashley M.","family":"Sidebottom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"pone.0337727.ref001","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev-micro-041020-022206","article-title":"Translating microbiome research from and to the clinic","volume":"76","author":"ZJ Zhang","year":"2022","journal-title":"Annu Rev Microbiol"},{"issue":"3","key":"pone.0337727.ref002","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/gutjnl-2020-321106","article-title":"Ranking microbiome variance in inflammatory bowel disease: a large longitudinal intercontinental study","volume":"70","author":"AG Clooney","year":"2021","journal-title":"Gut"},{"issue":"5","key":"pone.0337727.ref003","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/s41564-019-0442-5","article-title":"Author correction: Gut microbiome structure and metabolic activity in inflammatory bowel disease","volume":"4","author":"EA Franzosa","year":"2019","journal-title":"Nat Microbiol"},{"issue":"7533","key":"pone.0337727.ref004","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nature13828","article-title":"Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile","volume":"517","author":"CG Buffie","year":"2015","journal-title":"Nature"},{"issue":"1","key":"pone.0337727.ref005","doi-asserted-by":"crossref","first-page":"6615","DOI":"10.1038\/s41467-022-34260-2","article-title":"Immunomodulatory fecal metabolites are associated with mortality in COVID-19 patients with respiratory failure","volume":"13","author":"MR Stutz","year":"2022","journal-title":"Nat Commun"},{"issue":"1","key":"pone.0337727.ref006","doi-asserted-by":"crossref","first-page":"5695","DOI":"10.1038\/s41467-019-13498-3","article-title":"Metabolomics analysis of human acute graft-versus-host disease reveals changes in host and microbiota-derived metabolites","volume":"10","author":"D Michonneau","year":"2019","journal-title":"Nat Commun"},{"key":"pone.0337727.ref007","doi-asserted-by":"crossref","first-page":"1182534","DOI":"10.3389\/frtra.2023.1182534","article-title":"Reduced immunomodulatory metabolite concentrations in peri-transplant fecal samples from heart allograft recipients","volume":"2","author":"M Dela Cruz","year":"2023","journal-title":"Front Transplant"},{"issue":"11","key":"pone.0337727.ref008","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1038\/s41564-023-01493-w","article-title":"Bifidobacteria metabolize lactulose to optimize gut metabolites and prevent systemic infection in patients with liver disease","volume":"8","author":"MA Odenwald","year":"2023","journal-title":"Nat Microbiol"},{"issue":"1","key":"pone.0337727.ref009","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2023.11.016","article-title":"Fecal metabolite profiling identifies liver transplant recipients at risk for postoperative infection","volume":"32","author":"CJ Lehmann","year":"2024","journal-title":"Cell Host Microbe"},{"issue":"16","key":"pone.0337727.ref010","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1001\/jama.2023.4314","article-title":"VE303, a Defined bacterial consortium, for prevention of recurrent clostridioides difficile Infection: A randomized clinical trial","volume":"329","author":"T Louie","year":"2023","journal-title":"JAMA"},{"issue":"4","key":"pone.0337727.ref011","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2022.03.016","article-title":"Colonization of the live biotherapeutic product VE303 and modulation of the microbiota and metabolites in healthy volunteers","volume":"30","author":"M Dsouza","year":"2022","journal-title":"Cell Host Microbe"},{"key":"pone.0337727.ref012","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiaa689","article-title":"Current capabilities of gut microbiome-based diagnostics and the promise of clinical application","volume":"223","author":"GL Damhorst","year":"2021","journal-title":"J Infect Dis"},{"issue":"8","key":"pone.0337727.ref013","doi-asserted-by":"crossref","first-page":"100695","DOI":"10.1016\/j.gastha.2025.100695","article-title":"Fecal butyrate and deoxycholic acid concentrations correlate with mortality in patients with liver disease","volume":"4","author":"MA Odenwald","year":"2025","journal-title":"Gastro Hep Adv"},{"issue":"26","key":"pone.0337727.ref014","first-page":"2978","article-title":"Impact of gut colonization with butyrate-producing microbiota on respiratory viral infection following allo-HCT","volume":"131","author":"BW Haak","year":"2018","journal-title":"Blood"},{"key":"pone.0337727.ref015","doi-asserted-by":"crossref","first-page":"112867","DOI":"10.1016\/j.jpba.2019.112867","article-title":"Assessment of gut microbiota fecal metabolites by chromatographic targeted approaches","volume":"177","author":"J Fiori","year":"2020","journal-title":"J Pharm Biomed Anal"},{"issue":"7","key":"pone.0337727.ref016","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3390\/metabo10070282","article-title":"Development and validation of a highly sensitive LC-MS\/MS method for the analysis of bile acids in serum, plasma, and liver tissue samples","volume":"10","author":"C G\u00f3mez","year":"2020","journal-title":"Metabolites"},{"key":"pone.0337727.ref017","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jchromb.2009.01.039","article-title":"Application of liquid chromatography-mass spectrometry to measure short chain fatty acids in blood","volume":"877","author":"HMH van Eijk","year":"2009","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"7","key":"pone.0337727.ref018","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.1021\/acs.jproteome.1c00147","article-title":"Development of an efficient and sensitive chemical derivatization-based LC-MS\/MS method for quantifying gut microbiota-derived metabolites in human plasma and its application in studying cardiovascular disease","volume":"20","author":"H-Y Liao","year":"2021","journal-title":"J Proteome Res"},{"key":"pone.0337727.ref019","first-page":"678","article-title":"Standards and Certification:","volume":"493","author":"Clinical Laboratory improvement Amendments (CLIA) of 1988","journal-title":"Laboratory Requirements"},{"key":"pone.0337727.ref020","unstructured":"Chemistry and Toxicology Checklist, CAP Accreditation Program. College of American Pathologists. Edition: 08.24.2023."},{"issue":"17","key":"pone.0337727.ref021","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1080\/10643389.2014.1000761","article-title":"The characterization of feces and urine: A review of the literature to inform advanced treatment technology","volume":"45","author":"C Rose","year":"2015","journal-title":"Crit Rev Environ Sci Technol"},{"issue":"3","key":"pone.0337727.ref022","doi-asserted-by":"crossref","first-page":"105675","DOI":"10.1016\/j.jbc.2024.105675","article-title":"Fecal-adherent mucus is a non-invasive source of primary human MUC2 for structural and functional characterization in health and disease","volume":"300","author":"NN Fancy","year":"2024","journal-title":"J Biol Chem"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0337727","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T18:34:51Z","timestamp":1767983691000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0337727"}},"subtitle":[],"editor":[{"given":"Vasu D.","family":"Appanna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0337727","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]}}}